FDA | PBS NewsHour

The outside of the Food and Drug Administration headquarters is seen in White Oak, Md., on Monday, November 9, 2015. The FDA is a federal agency of the United States Department of Health and Human Services and has been in commission since 1906. Photo By Al Drago/CQ Roll Call

U.S. approves new drug to manage sickle cell disease, costs $85,000 to $113,000

By Linda A. Johnson, Associated PRess

Companies and Instagram influencers are selling cosmetic products for vulvas and "wellness" products for vaginas, which could put people at risk for infection and bacterial vaginosis. Photo by kvladimirv/via Adobe Stock

Beauty products for vulvas? These doctors say don’t buy it

Instagram influencers and companies are selling cosmetic products for vulvas and "wellness" products for vaginas, which could put people at risk for infection and bacterial vaginosis.

By Jamie Leventhal

U.S. finds contaminant in popular heartburn drug

For now, the Food and Drug Administration said patients can continue taking Zantac and related generic drugs.

By Matthew Perrone, Associated Press

Plastic surgeon Denis Boucq (R) operates a patient to remove her silicone gel breast implants manufactured by French company Poly Implant Prothese (PIP) in a clinic in Nice December 21, 2011. French medical device regulatory authority (AFSSAPS) recalled PIP breast implants in March 2010 after it concluded that their performance and safety were not in accordance with current standards. France will offer surgery to remove the breast implants of up to 30,000 women if a study due out this week finds that the silicone they are made from could cause cancer, the health minister said on Tuesday. Photo by: Eric Gaillard/Reuters

Breast implant recalled after link to more rare cancer cases

The U.S. Food and Drug Administration said it called for the removal after new information showed Allergan's Biocell breast implants with a textured surface were tied to the vast majority of cases of a rare form of lymphoma.

By Matthew Perrone, Associated Press

At first-ever public hearing on CBD, advocates and FDA try to blaze trail to regulatory compromise

The meeting on Friday was the public kickoff of the FDA’s quest to sketch a clear framework to regulate CBD, or cannabidiol, products.

By Nicholas Florko, STAT

FDA to end program that hid millions of reports on faulty medical devices

By Christina Jewett, Kaiser Health News

In the wake of a Kaiser Health News investigation, the agency will no longer let device makers file reports of harm outside a widely used public database.

U.S. halts sales of pelvic mesh tied to injuries in women

By Matthew Perrone, Associated Press

The Food and Drug Administration ordered the two remaining makers of the mesh to stop selling it immediately, saying the companies failed to show the mesh is safe for long-term use. The FDA action does not apply to surgical mesh…

FDA says it’s exploring CBD’s uses. Does it work — and is it legal?

By Carla K. Johnson, Candice Choi, Associated Press

Products containing CBD are already in stores and sold online, so it's easy to believe there must be something special about the ingredient. But the claims are largely unproven and quality control standards don't exist.

U.S. to require breast density information after mammograms

By Matthew Perrone, Associated Press

The Food and Drug Administration's proposed rules would standardize the information given to millions of women following scans to detect breast cancer.

FDA identifies a farm linked to the romaine lettuce E. coli outbreak

By Laura Santhanam

Adams Bros. Farms, the producer linked to the pre-Thanksgiving outbreak, has not shipped lettuce since Nov. 20 and has cooperated with the investigation, the FDA said in a statement.